SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CTIX - Cellceutix Corporation
An SI Board Since May 2008
Posts SubjectMarks Bans Symbol
106 17 0 CTIX
Emcee:  Savant Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
56 Cellceutix Reports Positive Results of Brilacidin in MicrobiologicalSavant-12/23/2014
55Superbugs Could Kill 10 Million People A Year, Report Warns 12/17/2014 7:45:31 Savant-12/17/2014
54Dec 10, 2014 07:40:00 (ET) Cellceutix: Prurisol(TM) for Psoriasis -- FDA AgreSavant-12/10/2014
53Cellceutix Antibiotic Brilacidin Receives QIDP Designation From FDA unsnip.. Savant-12/8/2014
52>>Cellceutix Antibiotic Brilacidin Receives QIDP Designation From FDA BEVEtuck-12/8/2014
51>>Cellceutix Announces Positive Top-Line Data From Phase 2b ABSSSI Trial; tuck110/23/2014
50Cellceutix to President Obama: We Have the Tools and Will Rise Up to the ChallenSavant-9/20/2014
49Cellceutix Anti-Psoriasis Drug Prurisol Meets Primary Endpoint of Clinical TrialSavant-8/7/2014
48Cellceutix Believes Brilacidin on Track to Help U.S. Avoid Falling Into Post-AntSavant-8/4/2014
47Cellceutix Brilacidin ABSSSI Trial Gets Positive Review by Data Safety MoSavant-7/15/2014
46Cellceutix Clinical Trial of Anti-Cancer Drug Kevetrin Entering Eighth Cohort EnSavant-7/14/2014
45Cellceutix Anti-Fungal Compounds Awarded $1.5 Million SBIR Grant BEVERLY, MA --Savant-7/14/2014
44RT... President's advisory group calls for clinical trial changes, incentivSavant-7/14/2014
43Cellceutix Announces Breakthrough in the Formulation of Its Novel AntibioSavant-7/14/2014
42Very nice SA article today.Buffalo Chip-1/14/2013
41Cellceutix Comments on New York Times Article Heralding p53 Drugs as the New AgeSavant-12/28/2012
40Cellceutix Announces Kevetrin Dosing Levels Increased as Clinical Trials AdvanceSavant-12/28/2012
39Cellceutix Corp. (CTIX.OB) Wraps Up Toxicology Studies as Human Trials Near for QualityStocks-8/24/2010
38Companies Vying for Position with Psoriasis Drugs as Industry Sets to Double to QualityStocks18/17/2010
37Autism’s New Hope For a parent, it’s difficult to imagine a more distressing diQualityStocks-8/11/2010
36Strength of Cellceutix, Inc. (CTIX.OB) Pipeline Results in Contracting of DestumQualityStocks-7/26/2010
35Cellceutix Corp. (CTIX.OB) Offers Hope to Cancer Industry and Opportunity to InvQualityStocks-7/20/2010
34Industry Attention Turning to Cellceutix Corp. (CTIX.OB) as a Result of Cancer aQualityStocks-7/12/2010
33Cellceutix Corp. (CTIX.OB) Announces Completion of All Three Animal Safety PharmQualityStocks-7/7/2010
32Cellceutix Corp. (CTIX.OB) Backed by Seasoned Management Team Cellceutix Corp. QualityStocks-6/29/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News